Copyright
©2011 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Aug 6, 2011; 2(4): 27-35
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Table 3 General characteristics of the sample (n =1004)
Patients characteristics | n (%) |
Gender | |
Males | 527 (52.5) |
Females | 477 (47.5) |
Age (yr, mean ± SD) | 54.6 ± 21.2 |
Unit | |
ICU | 142 (14.1) |
IM | 468 (46.6) |
Surgery | 190 (18.9) |
CCU | 94 (9.4) |
Pediatrics | 40 (4.0) |
OBGYN | 28 (2.8) |
Others | 42 (4.2) |
Hospital stay: Median and IQR (d) | 4.0 (5.0)1 |
Acid-suppressant drugs | |
PPIs | 618 (61.6) |
Omeprazole | 477 (47.5) |
Lansoprazole | 50 (5.0) |
Esomeprazole | 5 (0.5) |
Rabeprazole | 86 (8.6) |
H2-RAs | 386 (38.4) |
Ranitidine | 384 (38.2) |
Nizatidine | 2 (0.20) |
Duplicate therapy | 0 (0) |
- Citation: Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther 2011; 2(4): 27-35
- URL: https://www.wjgnet.com/2150-5349/full/v2/i4/27.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v2.i4.27